Mode grants contract with leading U.S. medical device company

Mode Sensors (MODE) is pleased to announce a collaboration agreement with a leading U.S. medical device manufacturer to test Re:Balans hydration monitoring wearable technology for a new patient indication. As part of the collaboration, MODE will provide both products and analytical services, for which the company will receive financial compensation.

"This partnership underscores the versatility and relevance of the Re:Balans technology across diverse patient populations," said Martin Engebretsen, CMO and co-founder of MODE. "The potential market impact is tremendous, and if successful, this project could prove commercially transformative for the company."